复方硫酸亚铁叶酸片在妊娠合并缺铁性贫血中的干预作用.docVIP

精品论文 参考文献 复方硫酸亚铁叶酸片在妊娠合并缺铁性贫血中的干预作用 湖北省鄂州市中心血站 湖北鄂州 436000 【摘 要】目的 探讨复方硫酸亚铁叶酸片在妊娠合并缺铁性贫血中的干预作用。方法 选择2014年1月-2015年2月我院接诊的80例妊娠合并缺铁性贫血患者将其按随机数表法均分为对照组和观察组。观察组40例患者，通过复方硫酸亚铁叶酸片进行治疗；对照组40例患者，使用一般铁剂的药物进行治疗。比较两组患者在治疗之后的红细胞、Hb、SF、临床疗效以及出现的不良反应。结果 在治疗之后，发现观察组红细胞、Hb以及SF明显较对照组低，有统计学意义（Plt;0.05）；在治疗之中，发现观察组出现的不良反应明显较对照组出现的状况低，两组数据比较具有统计学意义（Plt;0.05）；发现观察组患者的总有效率（90.0%）明显高于对照组（80.0%），有统计学意义（Plt;0.05）。结论 在治疗妊娠合并缺铁性贫血的时候，通过复方硫酸亚铁叶酸片有着良好的效果，并且安全性高，提高了临床疗效，出现的不良反应较少，值得在临床上推广和应用。 【关键词】复方硫酸亚铁叶酸片；妊娠合并缺铁性贫血；干预作用 [Abstract]Objective To evaluate tntervention effect of compound ferrous sulfate folic acid tablets in pregnant women with iron deficiency anemia.Methods Select January 2014 - February 2015，80 hospital admissions of pregnant women with iron deficiency anemia which according to the random number table method were divided into a control group and observation group.40 patients in the observation group，the compound ferrous sulfate by folic acid tablets for treatment；control group of 40 patients，the use of drugs for the treatment of general iron.Two groups were compared after treatment RBC，Hb，SF，clinical efficacy and adverse reactions occur.Results After the treatment，the observation group found RBC，Hb and SF were significantly lower than the control group，there was significant（P lt;0.05）；in the treatment，we found that adverse reactions observed compared with the control group showed significantly low status group had two data comparison group was statistically significant（P lt;0.05）；observation group were found overall response rate（90.0%）was significantly higher（80.0%），statistically significant（P lt;0.05）.Conclusion In the treatment of pregnant women with iron deficiency anemia，folic acid tablets by ferrous sulfate compound has a good effect，and high safety，improved clinical efficacy and less adverse reactions worthy of promotion and application in clinical practice. Key words Compound ferrous sulfate folic acid tablets；Iron deficiency anemia during pregnancy；Intervention